HUMAX Trademark

Trademark Overview

On Thursday, September 30, 2004, a trademark application was filed for HUMAX with the United States Patent and Trademark Office. The USPTO has given the HUMAX trademark a serial number of 79006609. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Thursday, November 19, 2015. This trademark is owned by Genmab A/S. The HUMAX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]

Chemicals used in industry and science, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]
humax

General Information

Serial Number79006609
Word MarkHUMAX
Filing DateThursday, September 30, 2004
Status706 - SECTION 71 ACCEPTED
Status DateThursday, November 19, 2015
Registration Number3018118
Registration DateTuesday, November 22, 2005
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]
Goods and ServicesChemicals used in industry and science, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, December 10, 2004
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenmab A/S
Party Type30 - Original Registrant
Legal Entity Type98 - Unknown
AddressDK
Party NameGenmab A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK
Party NameGenmab A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events

Event DateEvent Description
Thursday, December 9, 2004SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, December 10, 2004NEW APPLICATION ENTERED
Monday, May 2, 2005ASSIGNED TO EXAMINER
Monday, May 2, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 6, 2005ASSIGNED TO LIE
Thursday, May 12, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 10, 2005NOTICE OF PUBLICATION
Tuesday, August 30, 2005PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2005REGISTERED-PRINCIPAL REGISTER
Friday, February 24, 2006CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 16, 2006LIMITATION OF GOODS RECEIVED FROM IB
Thursday, July 15, 2010CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, February 25, 2011INTERNATIONAL REGISTRATION RENEWED
Friday, November 11, 2011NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 3, 2012TEAS SECTION 71 RECEIVED
Wednesday, June 27, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 27, 2012REGISTERED-SEC.71 ACCEPTED
Wednesday, June 27, 2012NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, March 27, 2013PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, March 4, 2014PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, March 27, 2014PARTIAL INVALIDATION PROCESSED BY THE IB
Tuesday, November 17, 2015TEAS SECTION 71 RECEIVED
Thursday, November 19, 2015REGISTERED-SEC.71 ACCEPTED
Thursday, November 19, 2015NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, July 19, 2016PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, July 19, 2016INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, February 9, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, February 9, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 20, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 8, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 26, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, April 15, 2021INTERNATIONAL REGISTRATION RENEWED
Friday, September 15, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 5, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, November 22, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, March 21, 2025NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 24, 2025TEAS SECTION 71 RECEIVED

Related Keywords

humax diseases deficiency immune syndrome other autoimmune acquired cardiovascular infectious aids